《冷藏食物区气态二氧化氯作为防腐剂缓释的安全性》

  • 来源专题:食物与营养
  • 编译者: 潘淑春
  • 发布时间:2016-05-06
  • Following a request from the European Commission, the EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) provides a scientific opinion regarding the safety of the use of gaseous chlorine dioxide (ClO2) as preservative that is slowly released in cold food storage areas.

    The chlorine gas is generated in situ from tubes that contain two reactants, which upon activation slowly release gaseous ClO2. The tubes are to be used in cold storage rooms or in refrigerators for domestic use. The Panel noted that the mode of generation of ClO2 proposed by the applicant is different from the ones already used and accepted so far.

    The Panel is aware that the use of the material proposed by the applicant may lead to inhalation of ClO2, but the possible risk resulting from exposure of the consumer by inhalation was not assessed because this is outside the remit of the Panel.

    The evaluation of the preservative effect of gaseous ClO2 is outside the remit of the Panel.

    The applicant has submitted a dossier in support of its application for the authorisation of gaseous ClO2 for use as a preservative in cold food storage areas. In consideration of the well-known reactive nature of gaseous ClO2, the Panel agreed to assess, as a first step, to what extent chlorinated species are generated by the interaction of gaseous ClO2, under the proposed conditions of use, with some model food matrices.

    To this end, and upon request from the Panel, the applicant generated additional data showing that, under the measured in-use conditions in a refrigerator, only a small amount of the total releasable ClO2 from the tube was detected. The maximum detected concentration of ClO2 was 0.043 ppm, which corresponds to 15 μg/120 L. The mean concentration was 0.029 ppm, which corresponds to 10.2 μg/120 L. The applicant also provided experimental data showing that the release of one of the two reactants during use was very low. The data covering a period of 28 days showed that only < 0.005% of the total amount of the gaseous reactant will be released during the intended application duration.

    From the data provided by the applicant, under domestic refrigerator-like experimental conditions, the treatment of model food matrices with gaseous ClO2 led to low amounts of by-products, did not produce chlorinated organic by-products, and chlorate was not detected in the model food matrices. The Panel considered that the data indicated the absence of formation of potentially adverse chlorinated compounds in the model food matrices used by the applicant. However, the Panel noted the limitations of the model food matrices; in addition owing to the type of cold area used (a domestic refrigerator) in which a small size tube was used to generate the gaseous chlorine ClO2, the consideration of absence of formation of potentially adverse compounds is restricted to these conditions and do not apply to larger areas where bigger tubes can be used.

    According to the applicant, the only by-products resulting from the proposed use of gaseous ClO2 are chlorite and chlorate; therefore, the safety of these by-products has been assessed. The toxicity database for chlorite and chlorate is limited, but did not indicate concern about a genotoxic or carcinogenic potential.

    The ANS Panel did not perform an estimate of exposure, because no potentially adverse substances were identified in the initial step of the assessment.

    The Panel concluded that, under the conditions of use proposed by the applicant, the consumption of foods treated with use of gaseous ClO2 under the proposed domestic refrigerator-like conditions of use would not be of safety concern.

    A new assessment would be warranted in case of any change in the conditions of use.

    The Panel recommended that the risk of inhalation of gaseous chlorine should be considered, particularly in the case of large cold storage areas. In this respect, the Panel draws attention to the risk of misuse e.g. large tubes for the production of ClO2 being used in domestic refrigerators.

相关报告
  • 《美国农业研究局研发的二氧化氯袋使农产品更安全》

    • 来源专题:农业科技前沿与政策咨询快报
    • 编译者:乌吉斯古楞
    • 发布时间:2017-11-28
    • 位于佛罗里达(Florida)的美国农业研究局(Agricultural Research Service,ARS)科学家们正在帮助一家公司研发一种旨在让农产品更加安全的小型塑料袋。这种塑料袋能够释放二氧化氯气体,消灭水果和蔬菜表面的大肠杆菌和其他病原体。 这种袋子约半张信用卡大小,可装入运输容器中。位于佛罗里达德尔雷海滩(Delray Beach)的生产商——沃伦瓦特技术公司(Worrell Water Technologies)是一家销售水体净化技术的公司,这种袋子是沃伦公司的新产品。沃伦公司希望将这种袋子推销给美国以及海外的农产品批发商和包装食品生产厂。 位于佛罗里达皮尔斯堡(Fort Pierce)美国农业研究局园艺研究实验室(U.S. Horticultural Research Laboratory)的植物病理学家白金和(JinheBai)以及他的同事们与沃伦公司一起合作研发出了这一袋子。白金和的研究领域是寻找减少农产品的病原体污染的方法。白表示,全世界生产的水果和蔬菜至少有25%在收割后由于微生物污染而腐烂或损失。如果农产品不清洗干净或是煮熟,产品表面的大肠杆菌和其他病原体可能引发疾病。作为一种预防措施,消毒杀菌剂常常用来杀灭农产品上的微生物。美国的粮食加工商一般会往清洗农产品的水中加入氯。在欧洲,二氧化氯有时被泵入储藏室来进行农产品消毒。但将二氧化氯装入一种专用塑料袋供农产品包装厂商和批发商使用还是头一次。 在前期研究中,白和他的同事们发现,过于迅速释放二氧化氯气体将造成水果的化学灼伤,因此团队用一种能够以较慢速度释放二氧化氯气体的半渗透薄膜重新设计了袋子。白说道:“我们测试了改良版袋子,发现这种袋子能以更加可控的速率释放二氧化氯,有了我们想要的效果。”白和同事们发现在包装、运输和存储条件均为典型条件时,将袋子放入盛有葡萄的纸板箱中与不放袋子储存相比,细菌和真菌病原体减少了10%。ARS在皮尔斯堡的一个志愿小组发现,这一处理方式并未改变葡萄的外观或是味道。其他实验室检测表明,带袋存储的嫁接葡萄番茄,其大肠杆菌水平降低至十万分之一。该袋子对其他农产品的消毒效果需要进行进一步的评估和研究。 使用这种袋子不会让农产品价格大幅上涨,袋子成本为几美分,一筐或一纸板箱只需要放置1到3个袋子。沃伦公司还曾资助了另一项研究,对这种袋子进行评估。公司预料在不远的将来就能获得联邦政府对这种的袋子的使用批准。 (编译 乌吉斯古楞)
  • 《食品添加剂E171:关于口服二氧化钛纳米颗粒的首次研究结果》

    • 来源专题:农业科技前沿与政策咨询快报
    • 编译者:乌吉斯古楞
    • 发布时间:2017-11-28
    • 国国家农业研究院(InstitutNationale de la RechercheAgronomigue, INRA)的研究人员联合法国食品环境和职业健康与安全管理局(ANSES),格勒诺布尔阿尔卑斯大学(CEA-Université Grenoble-Alpes),同步辐射光源(Synchrotron SOLEIL)和卢森堡科学技术研究所(Luxembourg Institute of Science and Technology),针对口服二氧化钛的影响进行了研究。 二氧化钛(或TiO2)是一种广泛使用于食品尤其是糖果中的添加剂 。在化妆品、防晒霜、涂料和建筑材料等许多产品中都存在着二氧化钛,通常在欧洲称作E171,在食品行业被广泛用作添加剂来增白或增加食品的不透明度。在牙膏和药品中很常见,在糖果、巧克力、饼干、口香糖和食品补充剂中也是如此。E171由微米和纳米颗粒组成,但它却不被称为“纳米材料”,因为它的纳米颗粒含量没有超过50%(实际含量在10-40%之间)。国际癌症研究中心(The International Agency for Research on Cancer, IARC)对吸入(职业接触)二氧化钛存在的风险进行了评估,最终评级为2B类致癌物,也就是可能对人体致癌。 一、二氧化钛对肠道及免疫系统的影响 研究人员们对实验老鼠进行E171口服实验,每天每公斤身体重量进行10毫克剂量的服用,这一过程与人通过食物来摄取E171的过程类似。研究人员们在这些实验老鼠的肝脏里发现了二氧化钛分子,首次证明了二氧化钛在生物活体中被肠道吸收并进入血液的事实。 二氧化钛纳米颗粒出现在小肠和结肠内壁,然后进入淋巴集结的免疫细胞的细胞核内,诱发肠道免疫反应。从淋巴集结的细胞因子产生缺陷到结肠黏膜出现微炎症现象,研究人员发现了一系列免疫反应不平衡现象。脾脏作为系统免疫的代表,当E171在试管内被激活后,免疫细胞接触到E171会增加促炎细胞因子的产生能力。 二、长期口服二氧化钛对早期结肠直肠癌有诱发和刺激作用 研究人员在100天内让老鼠以饮用水的方式定期口服二氧化钛。对于之前服用过实验致癌物的老鼠,口服TiO2导致癌前病灶变大。另外一组健康的老鼠在口服E171后,11只中有4只老鼠的肠上皮组织中出现了自发性癌前病灶。未服用E171的老鼠直到实验的最后也未发现异常。这些实验结果表明,E171能诱发并刺激早期结肠直肠癌。 这些研究也首次表明,添加剂E171是肠道及整个身体中二氧化钛纳米颗粒的来源之一,对免疫功能和结肠的癌前病灶都有影响。同时也说明在经济合作与发展组织(Organization for Economic Cooperation and Development, OECD)指导下继续观察癌症后期阶段的癌变情况,开展相关研究是合理的。这些研究为评估E171添加剂对人体的风险提供了新数据。 上述研究建立在Nanogut项目框架下,由法国食品环境和职业健康与安全管理局(French Agency for Food, Environmental and Occupational Health & Safety, ANSES)提供资金支持,属于涉及环境、健康与工作环境的法国国家研究项目(PNR EST),由INRA协调开展。尽管目前研究结果显示添加剂在结肠直肠癌的早期具有诱发和刺激作用,但仍没有证据证明其会对人类造成危害或导致疾病步入晚期。 (编译 乌吉斯古楞)